The detection of prostate cells by the reverse transcription‐polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate

ObjectiveTo determine whether prostate cells are disseminated into the circulation of patients after transurethral resection of the prostate (TURP), as assessed by a reverse transcription‐polymerase chain reaction (RT‐PCR) assay for prostate specific antigen (PSA) mRNA.

[1]  R. Figlin,et al.  Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients , 1998 .

[2]  G. Raj,et al.  Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. , 1997, The Journal of urology.

[3]  A. Alexander,et al.  Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. , 1997, Urology.

[4]  R. Vessella,et al.  Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. , 1997, Clinical chemistry.

[5]  T. Deguchi,et al.  Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. , 1997, British Journal of Cancer.

[6]  H. Frierson,et al.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.

[7]  J. Rosai,et al.  Polymerase chain reaction in the detection of micrometastases and circulating tumor cells , 1996, Cancer.

[8]  M. Benson,et al.  Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. , 1996, The Journal of urology.

[9]  R. Figlin,et al.  Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. , 1996, The Journal of urology.

[10]  J. Holland,et al.  Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. , 1996, The Journal of urology.

[11]  S. Loric,et al.  Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy , 1995, The Lancet.

[12]  B. Lacour,et al.  Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. , 1995, Clinical chemistry.

[13]  M. Benson,et al.  Molecular Stating of Prostate Cancer. II. A Comparison of the Application of an Enhanced Reverse Transcriptase Polymerase Chain Reaction Assay for Prostate Specific Antigen Versus Prostate Specific Membrane Antigen , 1995 .

[14]  W. Gerald,et al.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Benson,et al.  Enhanced reverse transcriptase‐polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer , 1995, Cancer.

[16]  M. Benson,et al.  Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. , 1995, The Journal of urology.

[17]  A. Deblasio,et al.  Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.

[18]  W. Catalona,et al.  Management of cancer of the prostate. , 1994, The New England journal of medicine.

[19]  M. Benson,et al.  Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.

[20]  T. Deguchi,et al.  Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1993, Cancer research.

[21]  C. Croce,et al.  Detection of hematogenous micrometastasis in patients with prostate cancer. , 1992, Cancer research.

[22]  B. Eisenstein,et al.  The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. , 1990, The New England journal of medicine.

[23]  F. Orr,et al.  Interactions of cancer cells with the microvasculature during metastasis 1 2 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  J. H. Harrison,et al.  Management of carcinoma of the prostate; study of hormonal and surgical therapy in 100 patients. , 1951, The American journal of medicine.